Sauesund, Ellen Steffenssen
Hertzberg, Silvia N. W.
Jørstad, Øystein Kalsnes
Moe, Morten Carstens
Erke, Maja Gran
Fosmark, Dag Sigurd
Petrovski, Goran
Article History
Received: 7 May 2024
Accepted: 1 July 2024
First Online: 6 July 2024
Competing interests
: Ø.K.J. has been a member of Bayer, Allergan, and Roche advisory boards, has received lecture fees from Bayer and Allergan, and is, together with M.C.M., part of a collaborative agreement with SJJ Solutions related to developing syringes and needles for intravitreal injection. M.C.M. has been a member of advisory boards at Bayer, Novartis, Roche, Apellis and Allergan and received lecture fees from Bayer and Roche. G.P. is a member of the advisory board for Bulbitech AS and Profundus, and received lecture fees from Roche, Allergan and Abbvie. All other authors had no conflict of interest to declare.